BioNTech Maps Oncology Push, $1B Buyback and Manufacturing Cuts at AGM

BioNTech NASDAQ: BNTX used its virtual annual general meeting to outline a transition year marked by leadership changes, continued investment in oncology, a planned share repurchase program and a restructuring of its manufacturing network.